Skip to main content
Caplight Logo









Quiver Bioscience

Quiver Bioscience

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.quiverbioscience.com/

Last Round

Grant

May 5, 2026

Total Funding Raised

$3.65M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Quiver Bioscience is a biotechnology company that offers a neuroscience research platform to accelerate the discovery of therapeutics for central nervous system disorders.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Infrastructure

Keywords

drug discovery platformAI drug discoveryCNS drug discoverydrug target identificationbiological foundation modelsall-optical electrophysiologyphenotypic screeningpatient-derived cell modelsiPSC modelsneurodevelopmental disorderschronic pain therapeuticshigh-throughput screeningpreclinical researchbiotech AIdrug safety assessmentin-silico drug discoveryASO therapeuticsorganoid intelligence

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Quiver Bioscience Comparables

Compare Quiver Bioscience with similar companies based on industry and business-model similarity.

Quiver Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AcuraStem
86%
Verge Genomics
82%
NeuCyte
80%

Quiver Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 5, 2026
StrategicApr 13, 2026
GrantSep 18, 2025
GrantJul 2, 2025
GrantJul 1, 2025
Grant
Mar 19, 2025

Key People

Founding team and executive leadership

Graham T. Dempsey

Founder And Chief Executive Officer

Founding Team

Owen McManus

Consulting Chief Technology Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 67% MoM.

  • May 16, 2026

    Monthly visitors increased 58% MoM.

Quiver Bioscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Quiver Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Quiver Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range46
Year Founded2013
Last FundingMay 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?